 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
1 to 8 of 8 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Strobel G. on PAPER: Trajkovic K. et al., 2008, Author Q&A with Mikael Simons and Lawrence Rajendran. Questions by Gabrielle Strobel.... 14 Mar 2008.
|
 |
 |
 |
 |
 |
Strobel G. on PAPER: Shumaker SA. et al., 2003, Reply by Alzforum Editors to Comment by Mikko Laakso
The election of this paper by... 11 Jan 2008.
|
 |
 |
 |
 |
 |
Strobel G. on PAPER: Moreno H. et al., 2007, Author Q&A with Scott Small. Questions by Gabrielle Strobel.
Q: Brad Hyman's... 12 Oct 2007.
|
 |
 |
 |
 |
 |
Strobel G. on NEWS: Butting Heads—Autopsies Fuel Debate on Football and Neurodegeneration, Note from the Alzforum editor: Today's 2 Feb 2007.
|
 |
 |
 |
 |
 |
Strobel G. on PAPER: Doglio LE. et al., 2006, Note by Alzforum Editor: This paper has been 31 Jan 2007.
|
 |
 |
 |
 |
 |
Strobel G. on PAPER: Chandra RK. et al., 2001, The validity of this article has been called into serious question by three journals. In January... 2 Jun 2004.
|
 |
 |
 |
 |
 |
Strobel G. on PAPER: Kneipp J. et al., 2002, Q & A with Gabrielle Strobel, ARF, and Dieter Nauman, Robert Koch Institute,... 29 Jun 2002.
|
 |
 |
 |
 |
 |
Strobel G. on PAPER: Feng R. et al., 2001, "This paper presents a fascinating, two-part hypothesis. It suggests that presenilin-1 is... 29 Jun 2002.
|
 |
 |
 |
 |
 |
 |
1 to 8 of 8 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Should the FDA be allowed to use data from overseas clinical trials? |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Absolutely, we are running out of viable subjects in the U.S. |
 |
 |
 |
 |
 |
 |
9 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Yes, so long as the data is reliable |
 |
 |
 |
 |
 |
 |
31 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the trials are not as rigorous |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the data should be repeated in the U.S. |
 |
 |
 |
 |
 |
 |
5 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the drug sponsors are just trying to cut corners |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Responses: 51 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Archived Polls |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |